Search Results 31-40 of 8499 for zerona

  1. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...

  2. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as ifosfamide and doxorubicin hydrochloride, work in different ...

  3. NL-201 in Patients With Relapsed or Refractory Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    Inclusion Criteria: Adult subjects with large B-cell lymphoma, including Diffuse large B-cell lymphoma (DLBCL) not otherwise specified, Primary mediastinal ...

  5. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness and safety of ANV419 monotherapy or the combination of ANV419 with anti-PD1 ...

  6. Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma - Mayo Clinic

    About this study. This randomized phase III trial studies how well combination chemotherapy (vincristine sulfate, dactinomycin, cyclophosphamide alternated ...

  7. A Study to Evaluate ION251 to Treat Patients with Relapsed/Refractory Multiple Myleoma - Mayo Clinic

    The purpose of this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory ...

  8. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  9. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    About this study. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come ...

  10. A Study to Evaluate Smartphone-based Fetal Heart Rate Monitor for Self Administration by Low-risk Pregnant Women - Mayo Clinic

    About this study. The purpose of this study is to evaluate the functionality and acceptability of HeraBEAT™ Smartphone based Fetal Heart Rate monitoring ...